本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Can-Fite Biopharma Ltd

1.03
+0.01000.98%
盘后1.040.0100+0.97%19:18 EDT
成交量:5.46万
成交额:5.60万
市值:1,367.63万
市盈率:-0.95
高:1.03
开:1.02
低:1.02
收:1.02
数据加载中...
2020/02/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/10

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2020/02/07

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/07

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/07

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/04

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/04

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/03

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2020/02/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/31

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/24

招股说明书

Registration statement for certain foreign private issuers
2020/01/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/08

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]